Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck
Blackstone Life Sciences startup Uniquity Bio emerged from stealth with an in-licensed drug candidate that could treat a wide range of immunology and inflammation indications. The antibody's target puts it in competition with drugs from AstraZeneca, Pfizer, and Sanofi.
When It Comes to Preventive and Proactive Wellness, Accessibility Is Key
Holistic care requires proactive pursuit of health services, which more people might seek if financing options are available to manage costs.
SmarterDx Rakes In $50M For Its AI That Helps Hospitals Capture More Revenue
SmarterDx — an AI startup that provides clinical review and quality audits for medical claims — closed a $50 million Series B funding round, bringing its total funding to date to $71 million.
AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup
AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications. The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better side effect profile.
Right-to-Repair Laws Could Threaten Healthcare Safety
Healthcare devices must be exempted from general right to repair legislation.